This is a competitive renewal application for a Rheurnatology Training Grant that was first funded in 1976. The goal of this Training Program is to prepare qualified individuals for careers as independent investigators in areas of basic and clinical research related to problems in rheumatic diseases. Eligible M.D. candidates will generally have completed clinical training in adult or pediatric rheumatology and must demonstrate a strong interest in research and in an academic career. Eligible Ph.D. candidates will have received a Ph.D. degree in molecular genetics, biochemistry, cell biology, immunology, or a related area of the life sciences. The Training Program includes a structured series of basic science lectures and research conferences designed to give trainees a conceptual framework in the relevant areas of biological science. M.D. trainees may also apply to be enrolled in a three month full time intensive research training course offered by the University of Michigan Medical School. The laboratory training period will include at least two years of research experience, with minimum concurrent clinical commitments. All trainees will apply for individual externally funded fellowships, and the Training Program will be used to support trainees for one to two years until they are able to obtain external funding. The faculty mentors for the Training Program include 20 M.D., Ph.D., and M.D./Ph.D. scientists with tenure track faculty appointments at the University of Michigan. Nine of these faculty members have appointments in the Division of Rheumatology and eleven are from other Departments or Divisions. Several faculty members have joint appointments in both clinical and basic science departments. The Training Program is also supported by collaborating faculty with clinical duties (both tenure track and non tenure track.). The collaborating faculty will participate in the Training Program but will not serve as primary mentors for trainees. The areas of scientific expertise represented by the faculty mentors include immunology, biochemistry, cell biology, and molecular genetics in fields of investigation related to current problems in the rheumatic diseases. The research programs of the Division of Rheumatology are supported by external research funding greater than $5,000,000 and by more than 15,000 square feet of laboratory space. The Training Program benefits greatly from support of the University of Michigan Multipurpose Arthritis Center. There is close interaction with the training programs in Immunopathology, Geriatrics, and Cellular and Molecular Biology. Emphasis over the past ten years on the recruitment of outstanding female and minority trainees has resulted in graduation of such individuals into academic positions, and this emphasis will be continued.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Institutional National Research Service Award (T32)
Project #
5T32AR007080-28
Application #
6622731
Study Section
Arthritis and Musculoskeletal and Skin Diseases Special Grants Review Committee (AMS)
Program Officer
Ader, Deborah N
Project Start
1976-07-01
Project End
2007-04-30
Budget Start
2003-05-01
Budget End
2004-04-30
Support Year
28
Fiscal Year
2003
Total Cost
$236,596
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
073133571
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Nagaraja, Vivek; Mara, Constance; Khanna, Puja P et al. (2018) Establishing clinical severity for PROMISĀ® measures in adult patients with rheumatic diseases. Qual Life Res 27:755-764
Tsou, Pei-Suen; Coit, Patrick; Kilian, Nathan C et al. (2018) EZH2 Modulates the DNA Methylome and Controls T Cell Adhesion Through Junctional Adhesion Molecule A in Lupus Patients. Arthritis Rheumatol 70:98-108
Ray, Donna; Strickland, Faith M; Richardson, Bruce C (2018) Oxidative stress and dietary micronutrient deficiencies contribute to overexpression of epigenetically regulated genes by lupus T cells. Clin Immunol 196:97-102
Sarkar, Mrinal K; Hile, Grace A; Tsoi, Lam C et al. (2018) Photosensitivity and type I IFN responses in cutaneous lupus are driven by epidermal-derived interferon kappa. Ann Rheum Dis 77:1653-1664
Homer, Kate LaRiviere; Warren, Jeffrey; Karayev, Dmitry et al. (2018) Performance of Anti-Topoisomerase I Antibody Testing by Multiple-Bead, Enzyme-Linked Immunosorbent Assay and Immunodiffusion in a University Setting. J Clin Rheumatol :
Fu, Jiaqi; Nogueira, Sarah V; Drongelen, Vincent van et al. (2018) Shared epitope-aryl hydrocarbon receptor crosstalk underlies the mechanism of gene-environment interaction in autoimmune arthritis. Proc Natl Acad Sci U S A 115:4755-4760
McCoy, Sara S; Reed, Tamra J; Berthier, Celine C et al. (2017) Scleroderma keratinocytes promote fibroblast activation independent of transforming growth factor beta. Rheumatology (Oxford) 56:1970-1981
Namas, Rajaie; Beydoun, Nassar; Meysami, Alireza (2017) Breast calcinosis in a patient with Dermatomyositis. Eur J Rheumatol 4:175-176
Hutchings, Kim M; Lisabeth, Erika M; Rajeswaran, Walajapet et al. (2017) Pharmacokinetic optimitzation of CCG-203971: Novel inhibitors of the Rho/MRTF/SRF transcriptional pathway as potential antifibrotic therapeutics for systemic scleroderma. Bioorg Med Chem Lett 27:1744-1749
Mor-Vaknin, Nirit; Saha, Anjan; Legendre, Maureen et al. (2017) DEK-targeting DNA aptamers as therapeutics for inflammatory arthritis. Nat Commun 8:14252

Showing the most recent 10 out of 57 publications